Jim Cramer Is All Aboard Union Pacific, But Shows No Love For Orphan Drugs

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Union Pacific UNP. “I think it's a really good stock to own,” he added.Supporting his view, BofA Securities analyst Ken Hoexter, on May 16, maintained Union Pacific with a Buy rating and raised the price target from $256 to $262.“I'm getting tired of the orphan drug model,” Cramer said when asked about BioMarin Pharmaceutical Inc. BMRN. “I don't think it works now.”As per the recent news, BioMarin, on May 16, agreed to acquire Inozyme for ...